X
  • News
Advanced Medical Solutions Group plc Logo Advanced Medical Solutions Group plc Logo
  • Home
  • About Us
    • Company
    • Quality and Regulatory
    • Innovation
    • Careers
      • Job listings
    • Corporate Social Responsibility
    • Modern Slavery Act
    • Gender Pay Report
    • Sealantis
  • Our Technologies
    • Alginates
    • Collagen
    • Cyanoacrylates
    • Foam
    • Hydrocolloid
    • Hydrogels
    • Internal Sealants
    • Oxidised Cellulose
    • Sutures
  • Our Divisions
    • Branded
      • LiquiBand®
      • ActivHeal®
      • RESORBA®
      • Partners
      • Request Information
    • OEM
      • Foams
      • Hydrogels
      • Hydrocolloids
      • Alginates
      • Film
      • Request Information
      • Downloads
  • Investor Relations
    • At a Glance
    • Our Business
      • Our Vision and Strategy
      • Our Business Model
    • Corporate Governance
      • Corporate Governance
      • Statement of Compliance
      • Board of Directors
      • Board Committees
        • Audit Committee
        • Nomination Committee
        • Remuneration Committee
      • Directors’ Responsibilities
      • Key Performance Indicators
      • Senior Management
    • Shareholder Information
      • AIM Rule 26 Information
      • Warning to Shareholders
      • Shareholder Analysis
      • Financial Calendar
      • Company Documents
      • Advisors
      • Analysts
    • Share Price Information
      • Shareholder Price Data
      • Share Price Calculator
      • Share Terms Glossary
    • Regulatory News (RNS)
    • Financial Reports
      • Annual / Interim Reports
      • Results & Presentations
    • Latest Financial Highlights
    • FAQs
    • RNS Alert Service
  • Contact
    • Our Locations
    • Make an Enquiry
  • Home
  • About Us
    • Company
    • Quality and Regulatory
    • Innovation
    • Careers
      • Job listings
    • Corporate Social Responsibility
    • Modern Slavery Act
    • Gender Pay Report
    • Sealantis
  • Our Technologies
    • Alginates
    • Collagen
    • Cyanoacrylates
    • Foam
    • Hydrocolloid
    • Hydrogels
    • Internal Sealants
    • Oxidised Cellulose
    • Sutures
  • Our Divisions
    • Branded
      • LiquiBand®
      • ActivHeal®
      • RESORBA®
      • Partners
      • Request Information
    • OEM
      • Foams
      • Hydrogels
      • Hydrocolloids
      • Alginates
      • Film
      • Request Information
      • Downloads
  • Investor Relations
    • At a Glance
    • Our Business
      • Our Vision and Strategy
      • Our Business Model
    • Corporate Governance
      • Corporate Governance
      • Statement of Compliance
      • Board of Directors
      • Board Committees
        • Audit Committee
        • Nomination Committee
        • Remuneration Committee
      • Directors’ Responsibilities
      • Key Performance Indicators
      • Senior Management
    • Shareholder Information
      • AIM Rule 26 Information
      • Warning to Shareholders
      • Shareholder Analysis
      • Financial Calendar
      • Company Documents
      • Advisors
      • Analysts
    • Share Price Information
      • Shareholder Price Data
      • Share Price Calculator
      • Share Terms Glossary
    • Regulatory News (RNS)
    • Financial Reports
      • Annual / Interim Reports
      • Results & Presentations
    • Latest Financial Highlights
    • FAQs
    • RNS Alert Service
  • Contact
    • Our Locations
    • Make an Enquiry
Home Investor Relations Shareholder Information Company Documents

Company Documents

2011

PDF (498 KB) - Proposed RESORBA Acquisition Circular

2007

PDF (3 MB) - AIM Admission Document
PDF (1 MB) - Proposed Capital Re-organisation Circular
  • Investor Relations
    • At a Glance
    • Our Business
      • Our Vision and Strategy
      • Our Business Model
    • Corporate Governance
      • Corporate Governance
      • Statement of Compliance
      • Board of Directors
      • Board Committees
        • Audit Committee
        • Nomination Committee
        • Remuneration Committee
      • Directors' Responsibilities
      • Key Performance Indicators
      • Senior Management
    • Shareholder Information
      • AIM Rule 26 Information
      • Warning to Shareholders
      • Shareholder Analysis
      • Financial Calendar
      • Company Documents
      • Our Advisors
      • Our Analysts
    • Share Price Information
      • Shareholder Price Data
      • Share Price Calculator
      • Glossary of Share Price Terms
    • Regulatory News Announcements (RNS)
    • Financial Reports and AGM Results
      • Annual / Interim Reports
      • Results and Presentations
    • Latest Financial Highlights
    • Frequently Asked Questions
    • RNS News Alert Service
    • Share Price
    • Regulatory News
    LSE (UK)

    Advanced Medical Solutions Group Plc trade on the LSE:AIM (symbol: AMS)

    313.00p 0.00%

    At 11:01pm GMT 24th August 2019

    Data delayed at least 15 minutes

    View More Share Information Investor Relations Page
    Notice of Interim Results

    Notice of Results

    8th August 2019
    Total Voting Rights

    Total Voting Rights

    31st July 2019
    FDA approval for two advanced woundcare ranges

    Regulatory Approval

    30th July 2019
    View All RNS

    Not sure what you are looking for? Why not Contact Us and we'll see if we can assist you further.

    About us
    • Company
    • Careers
    • Our Brands
    • Corporate Social Responsibility
    • Modern Slavery Act
    • Gender Pay Report
    • Sealantis
    Our Divisions
    • Branded
    • OEM
    Investor Relations
    • Our Business
    • Corporate Governance
    • Shareholder Information
    • Shareholder Privacy Notice
    • Share Price Information
    • Financial Reports
    Contact
    • Our Locations
    • Make an Enquiry
    • Sitemap
    • Privacy Policy
    © 2019 Advanced Medical Solutions Group plc
    • | Cookies
    • | Accessibility
    • | Disclaimer
    Advanced Medical Solutions Group plc Logo